VICTOZA - Liraglutide Peptide (Novo Nordisk)
Optimize your metabolic wellness with VICTOZA. Designed for precision and efficacy, this Liraglutide-based solution is manufactured to meet the highest pharmaceutical standards. Whether you are managing metabolic health or seeking targeted peptide support, VICT OZA provides the reliability and quality required for professional-grade applications.
Specifications
| Active Substance | Liraglutide |
| Form | 1 pen x 3 ml |
| Dosage | 0.6-1.8 mg/day |
| Manufacturer | Novo Nordisk |
Product Overview & How it Works
VICTOZA is a peptide-based formulation containing Liraglutide, a substance widely studied for its role in metabolic regulation. As a GLP-1 receptor agonist, the science behind this peptide focuses on mimicking the natural hormones in the body that regulate glucose and satiety.
By interacting with specific receptors, the active substance assists in the regulation of insulin secretion and metabolic response. This makes it an essential tool for those seeking a structured approach to weight and glucose management. Each unit is provided in a precision-metered pen, ensuring that dosage remains consistent with the prescribed 0.6-1.8 mg/day parameters. This level of control is vital for maintaining safety, authenticity, and consistent results in a professional setting.
Our commitment to excellence ensures that every batch is sourced from Novo Nordisk, providing you with peace of mind regarding purity, stability, and laboratory-tested excellence. This product is ideal for users who require high-purity peptides for metabolic support.